These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24292448)

  • 1. Incidence of colorectal cancer in BRCA1 and BRCA2 mutation carriers: results from a follow-up study.
    Phelan CM; Iqbal J; Lynch HT; Lubinski J; Gronwald J; Moller P; Ghadirian P; Foulkes WD; Armel S; Eisen A; Neuhausen SL; Senter L; Singer CF; Ainsworth P; Kim-Sing C; Tung N; Llacuachaqui M; Chornokur G; Ping S; Narod SA;
    Br J Cancer; 2014 Jan; 110(2):530-4. PubMed ID: 24292448
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The incidence of pancreatic cancer in BRCA1 and BRCA2 mutation carriers.
    Iqbal J; Ragone A; Lubinski J; Lynch HT; Moller P; Ghadirian P; Foulkes WD; Armel S; Eisen A; Neuhausen SL; Senter L; Singer CF; Ainsworth P; Kim-Sing C; Tung N; Friedman E; Llacuachaqui M; Ping S; Narod SA;
    Br J Cancer; 2012 Dec; 107(12):2005-9. PubMed ID: 23099806
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Breast cancer risks in women with a family history of breast or ovarian cancer who have tested negative for a BRCA1 or BRCA2 mutation.
    Metcalfe KA; Finch A; Poll A; Horsman D; Kim-Sing C; Scott J; Royer R; Sun P; Narod SA
    Br J Cancer; 2009 Jan; 100(2):421-5. PubMed ID: 19088722
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The incidence of leukaemia in women with BRCA1 and BRCA2 mutations: an International Prospective Cohort Study.
    Iqbal J; Nussenzweig A; Lubinski J; Byrski T; Eisen A; Bordeleau L; Tung NM; Manoukian S; Phelan CM; Sun P; Narod SA;
    Br J Cancer; 2016 May; 114(10):1160-4. PubMed ID: 26986251
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of uterine cancer for BRCA1 and BRCA2 mutation carriers.
    Lee YC; Milne RL; Lheureux S; Friedlander M; McLachlan SA; Martin KL; Bernardini MQ; Smith C; Picken S; Nesci S; Hopper JL; Phillips KA;
    Eur J Cancer; 2017 Oct; 84():114-120. PubMed ID: 28802188
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer.
    Risch HA; McLaughlin JR; Cole DE; Rosen B; Bradley L; Kwan E; Jack E; Vesprini DJ; Kuperstein G; Abrahamson JL; Fan I; Wong B; Narod SA
    Am J Hum Genet; 2001 Mar; 68(3):700-10. PubMed ID: 11179017
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of colorectal cancer associated with BRCA1 and/or BRCA2 mutation carriers: systematic review and meta-analysis.
    Cullinane CM; Creavin B; O'Connell EP; Kelly L; O'Sullivan MJ; Corrigan MA; Redmond HP
    Br J Surg; 2020 Jul; 107(8):951-959. PubMed ID: 32297664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cancers associated with BRCA1 and BRCA2 mutations other than breast and ovarian.
    Mersch J; Jackson MA; Park M; Nebgen D; Peterson SK; Singletary C; Arun BK; Litton JK
    Cancer; 2015 Jan; 121(2):269-75. PubMed ID: 25224030
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BRCA1/BRCA2 mutations in Japanese women with ductal carcinoma in situ.
    Liu Y; Ide Y; Inuzuka M; Tazawa S; Kanada Y; Matsunaga Y; Kuwayama T; Sawada T; Akashi-Tanaka S; Nakamura S
    Mol Genet Genomic Med; 2019 Mar; 7(3):e493. PubMed ID: 30652428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mammography screening and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers: a prospective study.
    Giannakeas V; Lubinski J; Gronwald J; Moller P; Armel S; Lynch HT; Foulkes WD; Kim-Sing C; Singer C; Neuhausen SL; Friedman E; Tung N; Senter L; Sun P; Narod SA
    Breast Cancer Res Treat; 2014 Aug; 147(1):113-8. PubMed ID: 25082516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Germ-line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen-responsive proteins and the predominance of progesterone receptor A.
    Mote PA; Leary JA; Avery KA; Sandelin K; Chenevix-Trench G; Kirk JA; Clarke CL;
    Genes Chromosomes Cancer; 2004 Mar; 39(3):236-48. PubMed ID: 14732925
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BRCA1 and BRCA2 mutations and the risk for colorectal cancer.
    Sopik V; Phelan C; Cybulski C; Narod SA
    Clin Genet; 2015 May; 87(5):411-8. PubMed ID: 25195694
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of Oophorectomy on Survival After Breast Cancer in BRCA1 and BRCA2 Mutation Carriers.
    Metcalfe K; Lynch HT; Foulkes WD; Tung N; Kim-Sing C; Olopade OI; Eisen A; Rosen B; Snyder C; Gershman S; Sun P; Narod SA
    JAMA Oncol; 2015 Jun; 1(3):306-13. PubMed ID: 26181175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endometrial Cancer Risk in Women With Germline BRCA1 or BRCA2 Mutations: Multicenter Cohort Study.
    de Jonge MM; de Kroon CD; Jenner DJ; Oosting J; de Hullu JA; Mourits MJE; Gómez Garcia EB; Ausems MGEM; Margriet Collée J; van Engelen K; van de Beek I; ; Smit VTHBM; Rookus MA; de Bock GH; van Leeuwen FE; Bosse T; Dekkers OM; van Asperen CJ
    J Natl Cancer Inst; 2021 Sep; 113(9):1203-1211. PubMed ID: 33710348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. BRCA1 and BRCA2 Gene Mutations and Colorectal Cancer Risk: Systematic Review and Meta-analysis.
    Oh M; McBride A; Yun S; Bhattacharjee S; Slack M; Martin JR; Jeter J; Abraham I
    J Natl Cancer Inst; 2018 Nov; 110(11):1178-1189. PubMed ID: 30380096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The incidence of endometrial cancer in women with BRCA1 and BRCA2 mutations: an international prospective cohort study.
    Segev Y; Iqbal J; Lubinski J; Gronwald J; Lynch HT; Moller P; Ghadirian P; Rosen B; Tung N; Kim-Sing C; Foulkes WD; Neuhausen SL; Senter L; Singer CF; Karlan B; Ping S; Narod SA;
    Gynecol Oncol; 2013 Jul; 130(1):127-31. PubMed ID: 23562522
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smoking and risk of breast cancer in carriers of mutations in BRCA1 or BRCA2 aged less than 50 years.
    ; ;
    Breast Cancer Res Treat; 2008 May; 109(1):67-75. PubMed ID: 17972172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Five screening-detected breast cancer cases in initially disease-free BRCA1 or BRCA2 mutation carriers.
    Shimada S; Yoshida R; Nakashima E; Kitagawa D; Gomi N; Horii R; Takeuchi S; Ashihara Y; Kita M; Akiyama F; Ohno S; Saito M; Arai M
    Breast Cancer; 2019 Nov; 26(6):846-851. PubMed ID: 30980249
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ovarian cancer risk in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations.
    Satagopan JM; Boyd J; Kauff ND; Robson M; Scheuer L; Narod S; Offit K
    Clin Cancer Res; 2002 Dec; 8(12):3776-81. PubMed ID: 12473589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cancer risks in Jewish male BRCA1 and BRCA2 mutation carriers.
    Laitman Y; Keinan Boker L; Liphsitz I; Weissglas-Volkov D; Litz-Philipsborn S; Schayek H; Friedman E
    Breast Cancer Res Treat; 2015 Apr; 150(3):631-5. PubMed ID: 25788227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.